209 related articles for article (PubMed ID: 26200108)
1. Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.
Oniki K; Saruwatari J; Izuka T; Kajiwara A; Morita K; Sakata M; Otake K; Ogata Y; Nakagawa K
PLoS One; 2015; 10(7):e0132640. PubMed ID: 26200108
[TBL] [Abstract][Full Text] [Related]
2. The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals.
Nishioji K; Mochizuki N; Kobayashi M; Kamaguchi M; Sumida Y; Nishimura T; Yamaguchi K; Kadotani H; Itoh Y
PLoS One; 2015; 10(10):e0140427. PubMed ID: 26485523
[TBL] [Abstract][Full Text] [Related]
3. PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.
Sun DQ; Zheng KI; Xu G; Ma HL; Zhang HY; Pan XY; Zhu PW; Wang XD; Targher G; Byrne CD; Chen YP; Yuan WJ; Zheng MH
Liver Int; 2020 Jan; 40(1):107-119. PubMed ID: 31519069
[TBL] [Abstract][Full Text] [Related]
4. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
[TBL] [Abstract][Full Text] [Related]
5. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
[TBL] [Abstract][Full Text] [Related]
6. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
7. Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population.
Wang S; Song J; Shang X; Chawla N; Yang Y; Meng X; Wang H; Ma J
BMC Med Genet; 2016 Dec; 17(1):90. PubMed ID: 27905898
[TBL] [Abstract][Full Text] [Related]
8. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD.
Targher G; Mantovani A; Alisi A; Mosca A; Panera N; Byrne CD; Nobili V
Hepatology; 2019 Jul; 70(1):142-153. PubMed ID: 30912854
[TBL] [Abstract][Full Text] [Related]
10. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
Xia MF; Lin HD; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Bian H; Li XY; Gao X
Diabetologia; 2019 Apr; 62(4):644-654. PubMed ID: 30673802
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease.
Bhatt SP; Nigam P; Misra A; Guleria R; Pandey RM; Pasha MA
Metab Syndr Relat Disord; 2013 Oct; 11(5):329-35. PubMed ID: 23734760
[TBL] [Abstract][Full Text] [Related]
12. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M
J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
[TBL] [Abstract][Full Text] [Related]
13. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
[TBL] [Abstract][Full Text] [Related]
14. High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study.
Alvares-da-Silva MR; Ivancovsky-Wajcman D; Oliveira CP; Rabie S; Longo L; Uribe-Cruz C; Yoshimura SM; Joveleviths D; Ben-Yehoyada M; Grinshpan LS; Shibolet O; Kariv R; Zelber-Sagi S
Eur J Clin Nutr; 2024 May; 78(5):442-448. PubMed ID: 38403728
[TBL] [Abstract][Full Text] [Related]
15. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.
Dai G; Liu P; Li X; Zhou X; He S
Medicine (Baltimore); 2019 Feb; 98(7):e14324. PubMed ID: 30762732
[TBL] [Abstract][Full Text] [Related]
16. The PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng Study.
Xia MF; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Lin HD; Gao X
Aliment Pharmacol Ther; 2019 Sep; 50(6):684-695. PubMed ID: 31250467
[TBL] [Abstract][Full Text] [Related]
17. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
[TBL] [Abstract][Full Text] [Related]
18. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD.
Hu DS; Zhu SH; Liu WY; Pan XY; Zhu PW; Li YY; Zheng KI; Ma HL; You J; Targher G; Byrne CD; Chen YP; Zheng MH
Diabetes Metab; 2020 Nov; 46(6):496-503. PubMed ID: 32035968
[TBL] [Abstract][Full Text] [Related]
20. A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease.
Moon S; Chung GE; Joo SK; Park JH; Chang MS; Yoon JW; Koo BK; Kim W
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):682-691.e8. PubMed ID: 33905771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
